Sialadenosis epidemiology and demographics
Sialadenosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sialadenosis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Sialadenosis epidemiology and demographics |
Risk calculators and risk factors for Sialadenosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
The incidence of sialadenosis 1000 per 100,000 individuals worldwide in autopsies.[1]
In1991 to 1995, the incidence of symptomatic sialadenosis was estimated to be 2.7 to 5.9 cases per 100,000 individuals in England.[2]
Percent of stones in different glands:[3]
- Submandibular glands: 80 to 92 percent
- Parotid glands: 6 to 20 percent
- Sublingual and minor salivary glands: 1 to 2 percent
Men develop more stones than women, and the majority of cases occur in individuals between the ages of 30 and 60 years. Stones rarely occur in children.
Incidence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Williams MF (1999). "Sialolithiasis". Otolaryngol. Clin. North Am. 32 (5): 819–34. PMID 10477789.
- ↑ Escudier MP, McGurk M (1999). "Symptomatic sialoadenitis and sialolithiasis in the English population, an estimate of the cost of hospital treatment". Br Dent J. 186 (9): 463–6. PMID 10365495.
- ↑ Mandel L (2014). "Salivary gland disorders". Med. Clin. North Am. 98 (6): 1407–49. doi:10.1016/j.mcna.2014.08.008. PMID 25443682.